Attitudes and perceptions of affected women towards endocrine endometriosis therapy: an international survey based on free-word association networks
article
OA: hybrid
CC0
⤵ 8 in-corpus citations
AI-generated summary
Endometriosis patients associate endocrine therapy with negative emotions and side effects, indicating a need for better physician communication and alternative treatments.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: What are the attitudes and perceptions towards endocrine endometriosis therapy? SUMMARY ANSWER: Among the study population, endocrine endometriosis therapies are associated with negative mental images and emotions and there seems to be a pre-therapeutic information deficit on the part of physicians. WHAT IS KNOWN ALREADY: Endocrine therapies, as the current standard of conservative endometriosis treatment, have good efficacy and improve symptoms and quality of life in most patients. Nevertheless, clinical practice repeatedly shows rejection on the part of patients, which may result in reduced compliance and discontinuation of therapy. STUDY DESIGN, SIZE, DURATION: Cross-sectional study among endometriosis patients using a multilingual questionnaire distributed via the most popular social media channels between November 2020 and February 2021. A total of 3348 women participated in the study. PARTICIPANTS/MATERIALS, SETTING, METHODS: Based on a pilot phase, an international, multilingual online survey was conducted among women affected by endometriosis. The questionnaire included free-word associations and questions about personal medical history, source of information, and demographic data. Mental representations were detected based on modules of the co-occurrence network of associations. MAIN RESULTS AND THE ROLE OF CHANCE: Six modules with different dominant emotional labels emerged from the confluence of associations to endocrine endometriosis therapy mentioned by participants. Five modules reflected negative mental associations, with the most frequently mentioned words being 'side effects', 'pain', 'ineffective', 'depression', and 'uncertainty'. Of the 12 most frequently selected emotions, only 'optimistic' was positive. Side effects affecting mental health are the most important reason for deciding against endocrine therapy in our survey population. Twenty-seven percent of respondents reported knowing little about endocrine therapies for endometriosis. Social media are the most frequently used sources of information and were rated as the most useful. LIMITATIONS, REASONS FOR CAUTION: By translating the questionnaire, questions might have been understood differently depending on the language. By using social media channels for distribution, digitally literate patients were targeted. The survey population might not be representative as patients who are critical/unhappy with therapy are more likely to seek advice from peer groups. WIDER IMPLICATIONS OF THE FINDINGS: The findings of this study replicate the findings of a recent survey in three European countries. Given the prevalence of endometriosis and the few emerging pharmaceutical alternatives, these data point to a growing need for further research and development of non-hormonal drugs for treating endometriosis. Most endometriosis patients are young and digitally literate, and much information is obtained from alternative sources, such as social media. Careful education before starting therapy should be taken seriously, and patients' concerns should be addressed individually by health care providers. This could help reduce misunderstanding and misinformation and improve treatment adherence and satisfaction. STUDY FUNDING/COMPETING INTEREST(S): There is no funding or conflict of interest to declare. TRIAL REGISTRATION NUMBER: The trial is not registered at any trial registry.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- An Overview of Treatments for Endometriosis via openalex
- An update on the pharmacological management of endometriosis via openalex
- Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science via openalex
- Elagolix for endometriosis: all that glitters is not gold via openalex
- Examining the Influence on Perceptions of Endometriosis via Analysis of Social Media Posts: Cross-sectional Study via openalex
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? via openalex
- Medical Management of Endometriosis via openalex
- Medical treatment of endometriosis-related pain via openalex
- Popularity of endocrine endometriosis drugs and limited alternatives in the present and foreseeable future: A survey among 1420 affected women via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- Self-management factors associated with quality of life among women with endometriosis: a cross-sectional Australian survey via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- W1574010683 via openalex
- W4292994367 via openalex
- W2013578576 via openalex
- W2070746915 via openalex
- W2148905283 via openalex
- W2614608184 via openalex
- W2810127666 via openalex
- W2887497037 via openalex
- W3034755522 via openalex
- W3099209941 via openalex
- W3134885188 via openalex
- W4214754424 via openalex
- W4234160457 via openalex
Cited by (8)
- Experiences towards hormonal treatments: a qualitative study among endometriosis patients and healthcare professionals 2026
- Polyzystisches Ovarialsyndrom und Endometriose – Konventionelle Therapien 2026
- Drug development for adenomyosis based on pathophysiology 2025
- Weighing up GnRH agonist therapy for endometriosis: outcomes and the treatment paradigm 2025
- Artificial intelligence in endometriosis care: A comparative analysis of large language model and human specialist responses to endometriosis-related queries 2025
- Emerging strategies for the treatment of endometriosis 2024
- A gluten-free diet for endometriosis patients lacks evidence to recommend it 2024
- Reply: Strengthening patient education on endometriosis therapies 2024
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-29T00:33:14.374400+00:00
License: CC0
· commercial use OK